The startup develops a healthcare technology platform that utilizes clinical and whole genome data to provide personalized cancer navigation for patients. By enabling access to tailored diagnostic and treatment options, the platform enhances outcomes-based cancer care for hospitals and clinicians.
Funding
Funding not disclosed
Founders
Product
Problem
Cancer patients often face a fragmented and overwhelming healthcare journey, lacking clear guidance on the most appropriate diagnostic and treatment options tailored to their specific genomic and clinical profiles. This can lead to delayed access to optimal care, increased anxiety, and potentially suboptimal outcomes.
Solution
This startup offers a healthcare technology platform that leverages clinical data and whole-genome sequencing to deliver personalized cancer navigation for patients. The platform analyzes individual patient data to identify tailored diagnostic and treatment options, providing clinicians and patients with actionable insights. By integrating comprehensive genomic information with clinical data, the platform aims to optimize treatment decisions, improve patient outcomes, and streamline the cancer care pathway. The platform facilitates access to precision medicine by matching patients with the most relevant therapies and clinical trials based on their unique cancer biology.
Target Audience
The primary target audience includes hospitals, oncologists, and other healthcare providers involved in cancer care, as well as cancer patients seeking personalized treatment options.
Features
- Integration of clinical data with whole-genome sequencing results for comprehensive patient profiling.
- AI-powered analysis to identify personalized diagnostic and treatment options.
- Matching of patients to relevant clinical trials based on genomic and clinical characteristics.
- Secure data storage and HIPAA compliance to protect patient privacy.
- Clinician dashboard for easy access to patient-specific recommendations and insights.